Desi Dwirosalia NS
Bosowa University

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Active Immunotherapy of Breast Cancer Treatment Desi Dwirosalia NS
Jambura Medical and Health Science Journal Vol 1, No 2 (2022): Jambura Medical and Health Science Journal
Publisher : Universitas Negeri Gorontalo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37905/jmhsj.v1i2.15357

Abstract

Immunotherapy as a specific moleculer targeted therapy could modulate immune respons through  cytotoxic CD8+ pathway so that generate anti-tumor activity on breast cancer. HER2/Neu is the one of  tumor associated antigen  which extensively studied to reduce cancer progression. CTLA-4 has important role in immune checkpoint blockade that it is used for studying breast cancer either in early or advanced level. In this review, we discussed principle of immunotherapy in tumor microenvironment and some kinds of active immunotherapies, which included cancer vaccination and immune checkpoint blockade. Majority of those immunotherapies are ongoing clinical trial.  Hence, this becomes a promising new field in breast cancer therapies in a future and will ultimately change the current status of breast cancer therapies.